Michael Wood | IR, LifeSci Advisors |
Dror Harats | CEO |
Amos Ron | CFO |
Kevin DeGeeter | Oppenheimer |
Sam Slutsky | LifSci Capital |
Ram Swayampakula | H.C. Wainwright |
Soumit Roy | Jones Trading |
Jonathan Kreizman | Valore Research |
Greetings and welcome to the VBL Therapeutics Fourth Quarter and Full Year 2019 Earnings Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator instructions].
As a reminder, this conference is being recorded.